Drug Type Small molecule drug |
Synonyms Clarithromycin/Amoxicillin/Vonoprazan Fumarate, Vonoprazan Fumarate/Amoxicillin Hydrate/Clarithromycin, Vonoprazan Fumarate/amoxicillin/Clarithromycin + [4] |
Mechanism 50S subunit inhibitors(50S ribosomal subunit inhibitors), CYP3A4 inhibitors(Cytochrome P450 3A4 inhibitors), P-CAB(Potassium-competitive acid blockers) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (25 Feb 2016), |
RegulationFast Track (US) |
Molecular FormulaC16H21N3O6S |
InChIKeyAIPFZZHNBUVELL-YWUHCJSESA-N |
CAS Registry61336-70-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Duodenal Ulcer | JP | 25 Feb 2016 | |
Gastritis | JP | 25 Feb 2016 | |
Helicobacter pylori infection | JP | 25 Feb 2016 | |
Marginal Zone B-Cell Lymphoma | JP | 25 Feb 2016 | |
Purpura, Thrombocytopenic, Idiopathic | JP | 25 Feb 2016 | |
Stomach Ulcer | JP | 25 Feb 2016 |
Not Applicable | - | nzqtnnanic(jsycovadzl) = cfvcklcfnw kqvhbxljja (mafcgumifa ) View more | - | 08 May 2023 |